Kelsey Watkins

Cooley advised Vivid Seats in connection with a repricing and incremental amendment to its credit agreement. Pursuant to the amendment, Vivid Seats refinanced all term loans outstanding immediately prior to the effectiveness of the amendment and incurred $125.5 million in additional term loans. The aggregate principal amount of term loans outstanding immediately after giving effect to the amendment was $395 million. Vivid Seats, which trades on the Nasdaq Global Select Market under the symbol SEAT, is an online ticket marketplace committed to becoming the ultimate partner for connecting fans to live events, artists and teams. Partner Michael Tollini led the Cooley team.

Cooley advised Reata Pharmaceuticals on a $275 million debt financing from funds managed by Pharmakon Advisors, and on an amendment and restatement of its development and commercialization funding agreement with affiliates of Blackstone Life Sciences. Reata – a global biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases –trades on the Nasdaq Global Market under the symbol RETA. Lawyers Michael Tollini, Mischi a Marca, Addison Pierce, Kelsey Watkins and Xueqing Li led the Cooley team.

Cooley advised Walnut on its $110 million Series A financing round. Partner Stephane Levy led the Cooley team advising Walnut, which is a provider of financial services intended to assist people in healthcare financing.